Liquid Biopsy

Liquid biopsy offers several advantages over traditional tissue biopsy, making it a revolutionary tool in precision medicine. This minimally invasive technique allows for real-time monitoring of tumor dynamics by detecting Exosomes, Circulating Tumor Cells (CTCs), cell-free DNA (cfDNA) and other biomarkers in bodily fluids such as blood.
Unlike conventional biopsies, which require invasive surgical procedures, liquid biopsy reduces patient discomfort, lowers the risk of complications, and enables frequent sampling for disease progression assessment. Additionally, it provides a more comprehensive view of tumor heterogeneity, capturing genetic variations from multiple metastatic sites.
These benefits make liquid biopsy an essential approach for early cancer detection, treatment response evaluation, and personalized therapy selection.